Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
Fixed Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Fixed Capital/Sales(x) 1.541.802.102.692.86

What is the latest Fixed Capital/Sales ratio of ORCHID PHARMA ?

The latest Fixed Capital/Sales ratio of ORCHID PHARMA is 1.54 based on Mar2024 Consolidated results.
Year Fixed Capital/Sales
Mar20241.54
Mar20231.80
Mar20222.10
Mar20212.69
Mar20202.86

How is Fixed Capital/Sales of ORCHID PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2024 1.54
-14.44
Mar2023 1.8
-14.29
Mar2022 2.1
-21.93
Mar2021 2.69
-5.94
Mar2020 2.86 -

Other Financial Ratios of ORCHID PHARMA


Compare Fixed Capital/Sales ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹3,930.8 Cr 9.9% -2.5% -28.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,136.0 Cr 6% 4% 9.9% Stock Analytics
DIVIS LABORATORIES ₹149,680.0 Cr 4.7% 0.3% 52.4% Stock Analytics
CIPLA ₹122,394.0 Cr 7% 3.7% 7.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,159.0 Cr 4.1% 6.4% 25% Stock Analytics
DR REDDYS LABORATORIES ₹97,105.6 Cr 6.3% 5% -4.7% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

9.9%

-2.5%

-28.7%

SENSEX

5.8%

6.1%

4.7%


You may also like the below Video Courses